Bullish option flow detected in Iovance Biotherapeutics with 5,278 calls trading, 1.8x expected, and implied vol increasing over 15 points to 108.93%. Jul-24 8.5 calls and Sep-24 14 calls are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.03. Earnings are expected on August 6th.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics submits MAA to EMA for lifileucel
- Jefferies healthcare analyst holds an analyst/industry conference call
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics price target lowered to $23 from $25 at JMP Securities